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thrombosis and dissection during carotid artery and stenting will also be discussed.
Knowledge of these additional skills is essential to increasing the safety of carotid stenting
procedures.
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Due to increasing Interventionist experience in conjunction
with optimization of pharmacotherapy before, during and
after carotid angioplasty with stenting (CAS) and the
development of dedicated tools (stents, embolic protection
devices), CAS has become a much safer procedure
compared with the early 1990s. However, there still
remains situations when immediate treatment of acute
neurological complications becomes necessary. These
complications generally follow a reduction of cerebral
blood flow due to embolization, thrombosis, or dissection in
the ipsilateral internal carotid artery (ICA) or its branches.
The fundamental aim of treating these complications is to
recanalise the occluding lesion with reperfusion of the811 6090.
oc.ch
ty for Vascular Surgery. Publishedistal arterial bed as soon as possible in order to salvage as
much penumbral tissue as possible, whilst avoiding hae-
morrhagic transformation.1,2
Procedural embolization
Embolization can occur as micro-emboli or macro-emboli. A
major reduction in micro-embolization can be achieved by
optimization of pre-operative pharmacological treatment
using anti-coagulant and antiplatelet therapy (e.g. Gp-IIb/
IIIa inhibitors). This allows for plaque stabilization prior to
performing the procedure. Using filter-type protection
devices, the overall number of micro-emboli (i.e. emboli
smaller than the pore-size of the filter) increases. However,
embolic protection devices do seem to reduce the number
of macro-embolic events (i.e. emboli larger than the pore-
size).3,4 Micro-emboli generally do not cause any acute
neurological deficit, but the long-term effects (e.g. on
cognition) remain unknown.d by Elsevier Ltd. All rights reserved.
Figure 1 Overview of some of the devices currently available
for mechanical retrieval of macro-emboli from the intracranial
circulation. (a), Merci retriever device (Concentric Medical,
Mountain View, CA). (b), Catch thrombus retriever system (Balt
Extrusion, Montmorency, France). (c), Proboscis Rx catheter
(Medical Braiding AG, Giswil, Switzerland). Note the large inner
lumen with a separate channel for rapid exchange wire and
kink resistance due to micro-braiding.
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emboli still occur and are related to incomplete deploy-
ment and/or vessel wall appositioning of the filter
devices,5,6 or they occur in cases of insufficient aspiration
of debris in the so-called dead-space when using distal
balloon protection devices. Finally, macro-embolization
can occur in a small number of patients because embolic
protection devices could not be used for technical reasons
or patient intolerance (e.g. balloon protection devices).7
Large emboli can be removed mechanically, or an
attempt can be made to dissolve them using thrombolytic
therapy. Mechanical removal of an embolus is particularly
helpful in cases where the embolus is likely to be derived
from the atherosclerotic plaque (cholesterol, lipid
debris8,9), i.e. unlikely to be effectively dissolved by
thrombolytic agents.
Mechanical removal of an embolus
Mechanical removal has a theoretical advantage over
thrombolytic therapy because it carries a lower risk of
bleeding (especially in cases where hyperperfusion is likely
to occur) and because the material that is dislodged is
expected to be more organized and/or non-thrombotic. In
the past, mechanical thrombectomy devices failed in the
intracranial vessels, primarily because of damage to the
vessel walls. Nowadays, safe mechanical removal of
embolic material from the main branches of the internal
carotid artery (i.e. until the proximal part of the M2-
segment) is possible using specific neuro-interventional
retrieval systems.
A number of devices are now available (Fig. 1) and can
be divided into two major subgroups according to their
mode of action. Proximal devices (e.g. aspiration cathe-
ters) apply a vacuum force to the proximal aspect of the
embolus. Distal devices (spiral-shaped or basket-like
devices) are advanced through the thrombus, thereby
allowing force to be applied to the distal segment of the
thrombus. The latter devices are typically introduced
through the pre-existing guiding catheter or long intro-
duction sheath and are advanced beyond the point of
occlusion in an un-deployed state using a microcatheter.
The two mechanical retrieval systems currently avail-
able (and approved) on the European market are the Merci
Retriever System (Concentric Medical, Mountain View, CA)
and the Catch device (Balt Extrusion, Montmorency,
France). The Merci Retriever System consists of the Merci
Clot retrieval device, the Merci balloon guide catheter, and
the Merci microcatheter. The retrieval device is a tapered
wire of thermal memory-encoded nitinol with 5 helical
loops of decreasing diameter (Fig. 1a). The balloon guide
catheter needs to be placed in the common or internal
carotid artery. Through this catheter, the microcatheter is
then advanced beyond the point of embolic occlusion (Figs.
2 and 3). Subsequently the Merci retriever is advanced
through the microcatheter until 2e3 helical loops are
deployed. The retriever is then withdrawn until contact
with the embolus is established. The microcatheter is then
withdrawn enabling the remaining loops of the retrieval
device to be deployed. Next, the balloon of the guiding
catheter is inflated to block or reduce antegrade flow in the
treated vessel and five clockwise rotations are applied to
the Merci retriever in order to fully ensnare the embolus.Finally, continuous aspiration is applied to the balloon
guide catheter while the retriever and microcatheter are
withdrawn simultaneously. Figs. 2 and 3 illustrate the
successful use of the Merci Retriever System in the carotid
and vertebrobasilar territories. This manoeuvre can be
repeated up to six times10 and adjunctive procedures (e.g.
intra-arterial thrombolysis) can be performed where
necessary. The clinical efficacy of the Merci retriever has
been reported in the MERCI trial and in a large single-centre
cohort in patients suffering from acute ischemic stroke (not
related to carotid angioplasty).10e14
The Catch thromboembolectomy device (Figs. 1b and 4)
comprises a self-expandable basket with radiopaque
markers (identifying the distal tip and the proximal opening
of the device) and a braided microcatheter (Vasco þ). The
system should be used in conjunction with a guiding cath-
eter of at least 6F. The microcatheter is advanced together
with the guidewire to a point that is located at least 2 cm
distal to the occlusion. After removal of the guidewire, the
Catch system is advanced through the occlusion, taking
care that the tip of the basket does not protrude beyond
the tip of the microcatheter. The basket is then opened by
withdrawal of the microcatheter. Upon full opening of the
basket, the whole system is withdrawn into the guiding
Figure 2 How to deal with acute embolic occlusion of the middle cerebral artery (MCA) using the Merci retriever device. (a),
Selective angiography of the left internal carotid artery in a patient with acute occlusion of the left MCA (arrowhead) that was not
related to a carotid stenting procedure. Note the poor distal perfusion (arrow). (b), Supra-selective angiography demonstrating tip
of microcatheter (arrowhead) beyond the point of occlusion. Distal MCA flow is better demonstrated (arrow). (c), Fluoroscopic
image demonstrating deployment of Merci retriever device in the left MCA (arrow). Note the balloon guiding catheter, with balloon
inflated (arrowhead). (d), Completion angiography demonstrating complete restoration of flow after mechanical thrombectomy.
(Images provided courtesy of Jan Albert Vos, MD, Nieuwegein, The Netherlands.)
Neuro-rescue during Carotid Stenting 629catheter (Fig. 4). A special re-sheathing hub is included in
the package to allow for multiple attempts to retrieve
embolic material.
In vivo testing using an animal model has shown that
distal mechanical devices are associated with a relatively
higher risk of spasm, but require significantly fewer
passages to achieve complete recanalization of the
occluded segment. They do, however, take longer than
proximal aspiration devices.15A comparison of the two
commercially available distal devices revealed a higher
fragmentation rate of thrombus using the Catch device,16
with both devices having the disadvantage of compressing
the thrombus when pulled back. Although not specificallyadvised by the manufacturer, use of the Catch device in
conjunction with proximal balloon occlusion and aspiration
during device retrieval seems to be essential in order to
reduce the number of distal emboli, and is therefore rec-
ommended by some authors.16
Potential sources of failure of mechanical retrieval
devices are excessive tortuosity of the arteries to be
negotiated, and the presence of a severe stenosis along the
pathway to the embolic occlusion.11 Complications of
retrieval devices include dissection (mainly related to the
use of the occlusion balloon with the Merci device),
embolization into a previously uninvolved vessel segment
and (intracranial) vessel perforation. Fracture of the coil of
Figure 3 How to deal with acute occlusion of the basilar artery using the Merci retriever device. (a) Selective angiogram of the
vertebrobasilar system demonstrating occlusion of the basilar artery (arrowhead). The tip of the microcatheter lies within the
occlusion (arrow). Note the hypoplastic left vertebral artery (curved arrow). (b), Selective angiography performed with the Merci
retriever in place (arrowhead). (c), Completion angiography showing recanalization of the basilar artery (arrowhead), and its distal
branches. (d), Image of removed clot and Merci retriever after removal from guiding catheter. (Images provided courtesy of Jan
Albert Vos, MD, Nieuwegein, The Netherlands.)
630 J.C. van den Bergthe Merci retriever (first generation device) and detach-
ment of the tip has also been described.10
Aspiration of an embolus/thrombus
Aspiration of thrombus from the common carotid artery or
cervical portion of the internal carotid artery using diag-
nostic or guiding catheters (diameter of 4Fe7F) has been
well described.17e19 When using diagnostic catheters, it is
important to use catheters without sideholes, otherwise no
vacuum can be obtained. The catheter should be advanced
until it smoothly contacts the thrombus, and negative
pressure is then applied using a 50 mL syringe. For aspira-
tion thrombectomy at the intracranial level, several
microcatheters are available (Vascoþ 35 (Balt); Proboscis
(Medical Braiding AG, Giswil, Switzerland); QuickCat
(Kensey Nash Corporation, Exton, PA); Diver (Invatec,
Roncadelle, Italy); and Export (Medtronic, Minneapolis,
MN)). Catheters used for this purpose (Fig. 1c) should have
a large inner lumen and should be kink-resistant (provided
by micro-braiding). If microcatheters are to be used for
aspiration, smaller syringes (<10 mL) should be used. In
vivo experiments have demonstrated similar effectiveness
regarding thrombus removal (as compared with distaldevices), although the use of aspiration catheters is asso-
ciated with an increased number of attempts to secure
recanalization.15 One important advantage of aspiration
catheters is that they can be used in situations where there
is limited space distal to the occlusion. In this situation, the
use of distal retrieval devices is precluded. An example of
aspiration thrombectomy in the vertebrobasilar system is
illustrated in Fig. 5.
Fragmentation techniques
In the acute situation (especially in the absence of dedi-
cated retrieval devices), restoration of antegrade flow can
be achieved by simply fragmenting the occluding embolus
using a balloon angioplasty catheter or by guidewire
manipulation.20 Wire fragmentation should be performed
using a flexible tip hydrophilic guidewire (0.00800e0.01000).
The wire tip should be formed into a J-shape in order to
avoid vessel wall perforation. Penetration and fragmenta-
tion of the thrombus can be achieved by gently advancing
and rotating the wire.21 Balloon angioplasty, however,
tends to be relatively ineffective, due to the spongy nature
of the clot/embolus that leads to instant recoil.1 In the
event of recoil, additional stent placement at the level of
Figure 4 How to deal with acute occlusion of the middle cerebral artery using the Catch device (a), Selective angiography of the
right internal carotid artery in a patient presenting with acute stroke (not related to a carotid stenting procedure) demonstrating
occlusion of the right middle cerebral artery (arrowhead). (b), Selective angiography of the right internal carotid artery after
passage of microguidewire (arrow) and microcatheter (arrowhead) beyond the point of occlusion. (c), Fluoroscopic image
demonstrating position of microcatheter (arrow) and retrieval device (Catch) with its markers (arrowheads), the retrieval device is
still in its non-deployed state. (d), Selective angiography after deployment of the retrieval device (markers indicated with
arrowheads) and after withdrawal of the device and microcatheter (arrow) into the siphon of the right internal carotid artery. (e),
Image of Catch retriever device and guiding catheter after complete withdrawal, demonstrating the presence of fresh clot in the
basket. (f), Selective control angiography of the right internal carotid artery demonstrating complete restoration of flow. (Images
courtesy of Professor Rene´ Chapot, Limoges, France.)
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able to reach the lesion, flexible stents and stent delivery
systems should be used. Best suited for this purpose are
CoeCr alloy stents used in percutaneous coronary inter-
ventions.23 The main disadvantage of the fragmentation
technique (and to a lesser extent stenting) is the relatively
high risk of distal embolization.
Intra-arterial thrombolysis
Intra-arterial thrombolysis has been shown to be an effec-
tive therapy for acute thrombotic occlusion of cerebralvessels and, as distinct from the retrieval devices, can be
used for small calibre distal occlusions in M2, M3 and higher
order MCA branches.24 The site of occlusion, type of
thrombus and presence of leptomeningeal collateralization
influences the likelihood of recanalization success. Typi-
cally, occlusions of the proximal carotid terminus and the
M1 segment of MCA respond poorly to intra-arterial
thrombolysis, mainly due to the large clot burden requiring
a much longer time for full enzymatic digestion.1 Although
a thrombus/embolus in the MCA may be successfully
treated with lysis, clinical success may be negatively
Figure 5 Aspiration thrombectomy. (a), Patient with acute vertebrobasilar stroke; coronal MPR reconstruction of CT angiography
demonstrating occlusion of the basilar artery (arrow). (b), Digital subtraction angiography in the same patient confirming embolic
occlusion of the basilar artery (arrow); a microcatheter has been advanced into the basilar artery (arrowhead). (c), Fluoroscopic
image in lateral projection after advancement of the catheter with tip of the catheter now against the embolus (arrowhead); note
the tortuosity in the distal part of the vertebral artery (arrow). (d), Completion angiography demonstrating complete restoration of
flow. (Images How to deal with acute embolic occlusion of the middle cerebral artery using the Merci retriever device courtesy of
Professor Gerhard Schroth, Bern, Switzerland.)
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branches. Commonly used thrombolytic agents include
urokinase and recombinant Tissue Plasminogen Activator
(rTPA) and are delivered through a super-selectively placed
microcatheter.
An infusion microcatheter (<3.0F) with a single end hole
should be placed into the proximal one third of the
thrombus using a steerable microguidewire (Fig. 6). Using
a so-called coaxial catheter technique, the microcatheteris advanced through an Y-connector attached to a diag-
nostic catheter with a lumen of at least 0.038’’. The Y-
connector also permits continuous flushing of the micro-
catheter with heparinized saline. If it proves impossible to
position the microcatheter within the thrombus, the tip of
the microcatheter needs to be placed as close to the
proximal aspect of the occlusion as possible.
A super-selective angiogram is then performed via the
microcatheter in order to confirm proper positioning of the
Figure 6 Intra-arterial thrombolysis. (a), Selective angiography of the left internal carotid artery (lateral projection) in a patient
suffering from an acute hemispheric neurological deficit after coronary angiography. The arrowhead marks the embolus occluding
the left middle cerebral artery. (b), Selective angiography of the left internal carotid artery (antero-posterior projection) in the
same patient; note presence of flow in the anterior cerebral artery (arrow) and absence of flow in the middle cerebral artery
(arrowhead). (c), Fluoroscopic image after positioning of microcatheter (arrowhead) for local, intra-arterial thrombolysis. (d),
Angiographic image after administration of 500,000 U of urokinase; partial recanalization (arrowhead) of the M1 segment of the
middle cerebral artery is seen with flow into peripheral (M2) branches (arrow). (e), Completion angiography demonstrating
complete restoration of flow. The clinical course was uneventful with complete regression of neurological symptoms.
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ally administered (500,000 IU urokinase with half being
administered as a single initial bolus). Alternatively,
a continuous infusion (without bolus) of up to 250,000 units
of urokinase over 90 min can be performed.21 rTPA may be
given as a 5-mg bolus followed by slow-infusion (maximum
dose 20 mg).25 It is of utmost importance to perform regular
angiograms during the period of thrombolysis (e.g. every
15 min) and to continue thrombolytic therapy until
complete recanalization has been achieved (up to
a maximum of 1 h). If any of the proximal thrombus
dissolves, the tip of the microcatheter has to be advanced
into the proximal portion of any remaining clot. Mechanical
disruption of the clot can also be performed in those situ-
ations where no lytic activity is observed.
As mentioned previously, intra-arterial thrombolysis
increases the risk of hemorrhagic complications. In the
PRO-ACT II trial of thrombolytic therapy, intracranial
hemorrhage within 24 h occurred in 35% (38/108) of treated
patients as compared with 13% (7/54) of control patients
(PZ 0.003).24 Selective intra-arterial administration of5 mg abciximab (ReoPro, Lilly Pharmaceuticals, Indian-
apolis, IN, USA) followed by a bolus of 5 mg abciximab
intravenously has also been demonstrated to be effective in
the treatment of acute neurological sequelae due to distal
embolization after carotid artery angioplasty and stent
placement.26 High recanalization rates (>75%) can be
achieved, when combining endovascular techniques such as
mechanical fragmentation of the thrombus, thromboaspi-
ration, percutaneous transluminal angioplasty, and
implantation of stents.27
Thrombosis during CAS
Thrombosis occurring during the CAS procedure seems to be
associated with the use of embolic protection devices (e.g.
filter devices), but acute thrombosis of the stented target
lesion has also been described. In addition, a large embolic
load may completely block the filter device leading to
proximal stasis of blood. There have also been cases where
thrombus forms on the wires of the filter system28 despite
maximum anti-coagulant therapy. Treatment consists of
local administration of abciximab or aspiration of thrombus
634 J.C. van den Bergfollowed by retrieval of the filter device using the guiding
catheter or sheath already in place29 (Fig. 7). Care should
be taken not to try to close the filter system completely, as
its embolicethrombotic contents may be squeezed out and
embolize distally.
Acute stent thrombosis is a rare (0.5e2%30) but poten-
tially fatal complication. It seems to be related to the lackFigure 7 Treatment of thrombus forming within an embolic
demonstrating filling defect (arrow) proximally from embolic prot
(b), Non-subtracted image of stent and filter device; the guiding ca
Angiogram after thromboaspiration and retrieval of the embolic pro
the internal carotid artery. (d), Close-up of embolic protection
(arrow) on the guidewire despite full antiplatelet and anticoagulatof (pre)treatment with combination antiplatelet therapy,31
although cases occurring despite pre-treatment with dual
antiplatelet therapy have been described.32 Treatment
consists of intra-arterial thrombolysis or administration of
intra-arterial abciximab.30,31,33 Intra-arterial thrombolysis
may involve administration of either urokinase or rTPA
using the dosage regimens described above.34 A successfulprotection device after CAS. (a), Periprocedural angiography
ection device (arrowhead); filling defect represents thrombus.
theter has already been advanced to the level of the stent. (c),
tection device using the guiding catheter confirming patency of
device (arrowhead) showing presence of thrombotic material
ion therapy.
Neuro-rescue during Carotid Stenting 635dosage-scheme of 0.25 mg/kg of abciximab intra-arterially,
followed by a continuous intravenous infusion (9 mg/min for
12 h) has been reported.33 Alternatively intra-carotid
injection of 5 mg rTPA, followed by systemic administration
of 5 mg rTPA and intra-carotid administration of a half-dose
bolus of abciximab (0.125 mg/kg) can be performed (so-
called facilitated thrombolysis).32
In rare situations where endovascular therapy and/or
systemic pharmacological treatment does not resolve the
occlusion rapidly, conversion to surgery using either
thrombendarterectomy with stent removal and patch
closure or thrombectomy using aspiration after transverse
arteriotomy of the ipsilateral common carotid artery should
be considered.35
Dissection during CAS
Dissection during CAS is rare and usually related to stent
placement, balloon angioplasty and distal balloon embolic
protection devices.7 In cases where flow reduction is
limited, a wait-and-see policy should be employed. In
situations where there is severe flow impairment, treat-
ment consists of either insertion of a second stent7 or
urgent surgical repair.36
In Conclusion
The majority of CAS procedures usually proceed without
any major complications. However, it is important to be
familiar with at least one mechanical neuro-interventional
retrieval system and one type of microcatheter when per-
forming carotid artery stenting. Knowledge of these devices
must be acquired in advance and not left to the emergency
situation. Similarly, the CAS operator should have Uroki-
nase, rTPA and/or abciximab available and be aware of the
dosage and administration regimes. Adding these additional
skills to the armamentarium of the interventionalist will
increase the safety of carotid stenting procedures even
further.
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